Vimarsana
Biggest News Aggregation in the World

Product Development Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Product Development Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Product Development Platform Today - Breaking & Trending Today

TRACON Pharmaceuticals Announces Reverse Stock Split - Vimarsana News

TRACON Pharmaceuticals Announces Reverse Stock Split

SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a...

TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue… - Vimarsana News

TRACON Pharmaceuticals Provides Update on Ongoing ENVASARC Phase 2 Pivotal Trial Following Independent Data Monitoring Committee Recommendation to Continue…

ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024 SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals TCON,…

Source: biztoc.com
Approximately USD 8 Million Investment for New Vaccine and Drug Development Against Malaria in Sumitomo Pharma, Mitsubishi Tanabe Pharma and New Product Development in NTDs - Vimarsana News

Approximately USD 8 Million Investment for New Vaccine and Drug Development Against Malaria in Sumitomo Pharma, Mitsubishi Tanabe Pharma and New Product Development in NTDs

/PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately 907 million yen (US$6.2 million1) for the...

Outer Selects Centric PLM™ as their Product Development Platform - Vimarsana News

Outer Selects Centric PLM™ as their Product Development Platform

CAMPBELL, Calif. (PRWEB) April 14, 2022 -- Outer, the eco-friendly outdoor furniture brand, has selected Centric Software®’s Product Lifecycle Management

Source: prweb.com
GHIT Fund Announces New Investments: A Total of 740 Million Yen for Malaria Drugs and Vaccine - Vimarsana News

GHIT Fund Announces New Investments: A Total of 740 Million Yen for Malaria Drugs and Vaccine

/PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of approximately 740 million yen (US$6.4 million*) to invest in...